Crossmark

Fructosamine and glycated hemoglobin as biomarkers of glycemic control in people with type 2 diabetes mellitus and cancer (GlicoOnco study)

Crossref DOI link: https://doi.org/10.1016/j.clinsp.2023.100240

Published Print: 2023-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Toyoshima, Marcos Tadashi Kakitani http://orcid.org/0000-0002-9146-4606
Cukier, Priscilla http://orcid.org/0000-0002-5254-0063
Damascena, Aline Santos

Batista, Rafael Loch http://orcid.org/0000-0002-5461-0301
de Azevedo Correa, Fernanda http://orcid.org/0000-0003-2107-9494
Zanatta Kawahara, Eduardo http://orcid.org/0009-0002-8054-2098
Minanni, Carlos André

Hoff, Ana O.

Nery, Marcia
Funding

Funding for this research was provided by:

Endocrine Society
License Information

Text and Data Mining valid from 2023-01-01

Text and Data Mining valid from 2023-01-01

Version of Record valid from 2023-06-16
More Information

This article is maintained by: Elsevier

Article Title: Fructosamine and glycated hemoglobin as biomarkers of glycemic control in people with type 2 diabetes mellitus and cancer (GlicoOnco study)

Journal Title: Clinics

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.clinsp.2023.100240

Content Type: article

Copyright: © 2023 HCFMUSP. Published by Elsevier España, S.L.U.